NCT05255393Completed
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
RELEVANT Prevalence of Patient-Reported Lymphedema Following Surgical Management of Cervical or Vulvar Cancer
Source: ClinicalTrials.gov · Last updated 21 Nov 2025
Brief summary (registry, in English)
The purpose of this study is to collect information that may identify people who are at risk of developing lower extremity lymphedema (LEL) after sentinel lymph node biopsy (SLN) during surgery for early-stage vulvar or cervical cancer, and to improve the quality and accuracy of the information that is given to people who have this procedure. Please note that, during this study, the researchers will collect information from a questionnaire completed by people who had SLN and LND+/- SLN during surgery for early-stage cervical or vulvar cancer. No form of treatment will be provided as part of the study, and no investigational tests or procedures will be performed.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 111 (actual)
- First submitted
- 16 Feb 2022
- Start date
- 15 Feb 2022
- Primary completion date
- 19 Nov 2025
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Cervical cancer
- NCT number
- NCT05255393
What you commit to
- Study type: Observational
- Participants enrolled: 111
- From 15 Feb 2022 to the primary completion date, 19 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Had documented macroscopic evidence of metastatic disease at the time of initial diagnosis
Who the study is looking for
- Presented to MSK with newly diagnosed early-stage cervical cancer of any histologic profile or early stage vulvar cancer of any histologic profile.
- °Early stage: Stage 1-2
- Underwent primary surgery at our institution between January 2006 and January 2022.
- Alive at the time of study activation
- English comprehension
- Capable of providing informed consent
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.